20:17 ETÜber den Horizont hinaus, gemeinsam immer weiter | Kexing Biopharm zieht Bilanz für seine Teilnahme an der CPHI & PMEC China 2026prnewswire·Jun 24 at 07:19 PM688136-3.78%
23:39 ETBeyond Horizons, Forward Together | Kexing Biopharm Concludes Participation in CPHI & PMEC China 2026prnewswire·Jun 23 at 10:40 PM688136-3.78%
10:23 ETUpdate zu innovativem Arzneimittel | Kexing Biopharm nimmt ersten Studienteilnehmer in die in China durchgeführte klinische Phase-I-Studie mit dem innovativen ophthalmologischen Arzneimittel GB10 aufprnewswire·Jun 5 at 09:25 AM688136-3.78%
06:53 ETInnovative Drug Update | Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10prnewswire·Jun 4 at 05:55 AM688136-3.78%
Sinovac Biotech: GB19 injection receives FDA Investigational New Drug approvalWallstreetcn·Mar 30 at 04:40 AM688136-3.78%
Shanghai Composite Nears Positive Territory, Pharmaceutical Stocks Surge, Computing Hardware Stocks Continue to Adjust, HSI Fluctuates Higher, New Consumption Concept Stocks Rebound, POP MART Rises 2%Wallstreetcn·Mar 27 at 03:46 AM688302-4.88%600513+9.97%
The A-share innovative drug concept fluctuated and declined, with SDKX falling over 10%. INNOSTAR, HITECK, Aidea Pharma, Chemexpress, and Beilu Pharma had significant declinesWallstreetcn·Mar 19 at 01:30 AM300016-2.69%688136-3.78%
